Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet TherapyAn ACTIVE W Substudy
Stefan H. Hohnloser, MD, FACC*,*,
Dimitri Pajitnev, MD*,
Janice Pogue, PhD ,
Jeff S. Healey, MD,
Marc A. Pfeffer, MD, FACC ,
Salim Yusuf, MD, FACC,
Stuart J. Connolly, MD, FACC for the ACTIVE W Investigators
* Department of Cardiology, Division of Electrophysiology, J. W. Goethe University, Frankfurt, Germany
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Brigham and Women's Hospital, Boston, Massachusetts
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Incidence of Stroke or Non-CNS Systemic Embolism According to Type of AF
Cumulative hazard rates of stroke and non-central nervous system (CNS) systemic embolisms in patients with paroxysmal (P) versus sustained (S) atrial fibrillation (AF) treated with aspirin plus clopidogrel or oral anticoagulation.
|
|
View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Stroke and Non-CNS Systemic Embolism According to Treatment Allocation
Cumulative hazard rates of stroke and non-central nervous system (CNS) systemic embolisms according to treatment allocation in patients with paroxysmal (left) versus sustained (right) atrial fibrillation. C+A = clopidogrel + aspirin; OAC = oral anticoagulation.
|
|
|
